143 related articles for article (PubMed ID: 19304323)
1. GATA-2 L359 V mutation is exclusively associated with CML progression but not other hematological malignancies and GATA-2 P250A is a novel single nucleotide polymorphism.
Zhang SJ; Shi JY; Li JY
Leuk Res; 2009 Aug; 33(8):1141-3. PubMed ID: 19304323
[TBL] [Abstract][Full Text] [Related]
2. Mutations of the myeloid transcription factor CEBPA are not associated with the blast crisis of chronic myeloid leukaemia.
Pabst T; Stillner E; Neuberg D; Nimer S; Willman CL; List AF; Melo JV; Tenen DG; Mueller BU
Br J Haematol; 2006 May; 133(4):400-2. PubMed ID: 16643447
[TBL] [Abstract][Full Text] [Related]
3. Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia.
Nakayama H; Ishimaru F; Avitahl N; Sezaki N; Fujii N; Nakase K; Ninomiya Y; Harashima A; Minowada J; Tsuchiyama J; Imajoh K; Tsubota T; Fukuda S; Sezaki T; Kojima K; Hara M; Takimoto H; Yorimitsu S; Takahashi I; Miyata A; Taniguchi S; Tokunaga Y; Gondo H; Niho Y; Harada M
Cancer Res; 1999 Aug; 59(16):3931-4. PubMed ID: 10463586
[TBL] [Abstract][Full Text] [Related]
4. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
Strnad M; Brajuskovic G; Strelic N; Todoric-Zivanovic B; Stamatovic D; Tatomirovic Z; Magic Z
J BUON; 2008; 13(3):403-8. PubMed ID: 18979557
[TBL] [Abstract][Full Text] [Related]
5. Is p190 bcr-abl rearrangement necessary for acute transformation in some p210 CML of childhood?
Scrideli CA; de Oliveira FM; Brassesco MS; de Paula Queiroz R; Bernardes JE; Valera ET; Tone LG
Leuk Res; 2009 Mar; 33(3):495-9. PubMed ID: 18495245
[TBL] [Abstract][Full Text] [Related]
6. Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia.
Zhang SJ; Ma LY; Huang QH; Li G; Gu BW; Gao XD; Shi JY; Wang YY; Gao L; Cai X; Ren RB; Zhu J; Chen Z; Chen SJ
Proc Natl Acad Sci U S A; 2008 Feb; 105(6):2076-81. PubMed ID: 18250304
[TBL] [Abstract][Full Text] [Related]
7. Expression and functional significance of osteocalcin splicing in disease progression of hematological malignancies.
Wihlidal P; Varga F; Pfeilstöcker M; Karlic H
Leuk Res; 2006 Oct; 30(10):1241-8. PubMed ID: 16387359
[TBL] [Abstract][Full Text] [Related]
8. p53 gene alterations in human hematological malignancies: a review.
Soussi T; Jonveaux P
Nouv Rev Fr Hematol (1978); 1991; 33(6):477-80. PubMed ID: 1818301
[TBL] [Abstract][Full Text] [Related]
9. Additional clonal abnormalities in Philadelphia-positive ALL and CML demonstrate a different cytogenetic pattern at diagnosis and follow different pathways at progression.
Bacher U; Haferlach T; Hiddemann W; Schnittger S; Kern W; Schoch C
Cancer Genet Cytogenet; 2005 Feb; 157(1):53-61. PubMed ID: 15676148
[TBL] [Abstract][Full Text] [Related]
10. The spectrum of adult B-lymphoid leukemias with BCR-ABL: molecular diagnostic, cytogenetic, and clinical laboratory perspectives.
Klco JM; Kreisel FH; Zehnbauer BA; Kulkarni S; Hassan A; Frater JL
Am J Hematol; 2008 Dec; 83(12):901-7. PubMed ID: 18932238
[TBL] [Abstract][Full Text] [Related]
11. High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression.
Boultwood J; Perry J; Zaman R; Fernandez-Santamaria C; Littlewood T; Kusec R; Pellagatti A; Wang L; Clark RE; Wainscoat JS
Leukemia; 2010 Jun; 24(6):1139-45. PubMed ID: 20410925
[TBL] [Abstract][Full Text] [Related]
12. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
Zhu Y; Xu W; Liu Q; Pan J; Qiu H; Wang R; Qiao C; Jiang Y; Zhang S; Fan L; Zhang J; Shen Y; Xue Y; Li J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):579-82. PubMed ID: 18841577
[TBL] [Abstract][Full Text] [Related]
13. Repetitive DNA hypomethylation in the advanced phase of chronic myeloid leukemia.
Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; San Jose-Eneriz E; Garate L; Cordeu L; Cervantes F; Prosper F; Heiniger A; Torres A
Leuk Res; 2008 Mar; 32(3):487-90. PubMed ID: 17765966
[TBL] [Abstract][Full Text] [Related]
14. GATA1 mutational analysis in chronic myeloid leukaemia.
Halsey C; Fisher C; Strathdee G; Gibson B; Holyoake T; Vyas P; Graham G
Br J Haematol; 2007 May; 137(4):375-6. PubMed ID: 17408401
[No Abstract] [Full Text] [Related]
15. Haploinsufficiency and acquired loss of Bcl11b and H2AX induces blast crisis of chronic myelogenous leukemia in a transgenic mouse model.
Nagamachi A; Yamasaki N; Miyazaki K; Oda H; Miyazaki M; Honda Z; Kominami R; Inaba T; Honda H
Cancer Sci; 2009 Jul; 100(7):1219-26. PubMed ID: 19432895
[TBL] [Abstract][Full Text] [Related]
16. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.
Mullighan CG; Miller CB; Radtke I; Phillips LA; Dalton J; Ma J; White D; Hughes TP; Le Beau MM; Pui CH; Relling MV; Shurtleff SA; Downing JR
Nature; 2008 May; 453(7191):110-4. PubMed ID: 18408710
[TBL] [Abstract][Full Text] [Related]
17. Chronic myeloid leukaemia as a model of disease evolution in human cancer.
Melo JV; Barnes DJ
Nat Rev Cancer; 2007 Jun; 7(6):441-53. PubMed ID: 17522713
[TBL] [Abstract][Full Text] [Related]
18. Coding sequence and intron-exon junctions of the c-myb gene are intact in the chronic phase and blast crisis stages of chronic myeloid leukemia patients.
Bussolari R; Candini O; Colomer D; Corradini F; Guerzoni C; Mariani SA; Cattelani S; Silvestri C; Pecorari L; Iacobucci I; Soverini S; Fasano T; Martinelli G; Cervantes F; Calabretta B
Leuk Res; 2007 Feb; 31(2):163-7. PubMed ID: 16797705
[TBL] [Abstract][Full Text] [Related]
19. Imatinib resistance and progression of CML to blast crisis: somatic hypermutation AIDing the way.
Strout MP; Schatz DG
Cancer Cell; 2009 Sep; 16(3):174-6. PubMed ID: 19732715
[TBL] [Abstract][Full Text] [Related]
20. Discovery of somatic mutations in the progression of chronic myeloid leukemia by whole-exome sequencing.
Huang Y; Zheng J; Hu JD; Wu YA; Zheng XY; Liu TB; Chen FL
Genet Mol Res; 2014 Feb; 13(1):945-53. PubMed ID: 24634115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]